Click here to register for all our upcoming webinars.
Supply Chain Series
Integrating the healthcare & life sciences supply chain
A helicopter view of each stage of the healthcare and life sciences supply chain lifecycle and an overview of the trends that businesses in the sector should consider in 2021 and beyond, including sustainability, digitalization and increased public funding.
Creating value through healthcare & life sciences M&A: A supply chain reaction
A look at the challenges and opportunities for supply chain transformation via M&A in the healthcare and life sciences space as well as how to create value in an uncertain transactional market.
Keeping supply chain risks at bay: A healthcare & life sciences view
Explores the compliance challenges and risks facing the healthcare and life sciences supply chain, which are being driven by digital transformation and the global health crisis.
Tax-ready supply chain management for healthcare & life sciences companies
An analysis of the tax implications that may arise as healthcare and life sciences companies reevaluate their supply chains, as well as strategic considerations when exploring alternatives to sourcing, manufacturing and other topics.
Are your trade secrets protected? Handling trade secrets in your global supply chain ecosystem
A look at the issues arising from data protection, R&D, advertising and promotions and handling trade secrets owned by third parties, as well as how healthcare and life sciences companies can limit their exposure. The session also discusses the impact of the COVID-19 pandemic on maintaining protection of trade secrets.
Cannabis, Hemp and Psychedelics: The regulatory landscape across 100 jurisdictions
Contact Cristina Barrobes for a copy of the recording.
The session presents a panoramic overview of the rules regulating cannabis across 100 markets through our unique and interactive global survey, which provides insight into the evolving state of cannabis and hemp laws across the world.
Conducting clinical trials in Australia
In partnership with Austrade, Bellberry and IQVIA, the webinar explores how to conduct clinical trials in Australia, including the benefits, process, due diligence issues and how to apply for an R&D tax incentive.
A similar webinar geared towards Chinese and Korean companies conducting or are interested to conduct clinical trials in Australia is also available.
Access the sessions: China webinar (in Mandarin) | Korea webinar (English)
Compliance issues arising out of global clinical trials
The session explores a case study on compliance issues arising out of global clinical trials such as local regulatory and compliance issues, FDA regulatory issues, FCPA and anti-bribery issues, and M&A red flags.
16th annual healthcare industry legal and compliance forum
Contact Cristina Barrobes and Rosie Slade for a copy of the recording.
A look at the key compliance issues companies need to consider before (due diligence), during (representation and warranties) and after (cleanup) any M&A transaction.
Tech Talk Silicon Valley 2021: HealthTech – Key Trends
Contact Sharon Byrne for a copy of the recording.
A panel of experts provide their insights on risk management, including how regulation can dovetail with the monetization of HealthTech transactions and activities.
Asia Pacific digital transformation in healthcare & life sciences
Our regional experts cover the legal and regulatory implications across the full product life cycle such as R&D, collaboration and licensing, telemedicine, product launch and promotions, as well as product liability and risk management in case of an adverse event.
EU Medical Devices
Introduction to EU medical devices regulations
This webinar analyzes the drivers behind the main changes of the new EU regulations for medical devices (MDR) and in vitro diagnostic medical devices (IVDR) as well as covers the impact of Brexit.
New EU data protection regulation and impact on medical devices
The session takes a look at the General Data Protection Regulation (GDPR), the impact of Brexit on the implementation and a four-step approach "fit for GDPR."
Hot in Healthcare Series
Melding health and tech with M&A: Are you buying the right tools with the right partners?
Explores how healthcare companies, technology companies and financial investors can succeed in M&A within the digital health space.
What IS hot in healthcare?
This session analyzes current and projected trends for digital health, including the challenges in introducing new technologies to the UK market and how to overcome them.
What IS hot, politically?
A look at the current political climate in terms of COVID-19 and Brexit, while exploring the UK's life sciences industry, trade negotiation position and other issues arising from the pandemic.
How hot is your data?
Looks into the legal hurdles and ethics of patient data by exploring how to build patient trust in digital health and by understanding the value of healthcare data and commercial models for data sharing.
Lessons from COVID-19: Compulsory licensing in a new world
Contact Grace Gato for a copy of the recording.
A region-by-region look at the evolving compulsory licensing regimes and how they are being shaped by the pandemic.
Australian patent box policy and implications for medical and biotech investors
Experts from Austrade, Baker McKenzie and IQVIA discuss the Patent Box scheme, an Australian Government initiative designed to encourage investment in medical and biotechnology innovation.
Spotlight on trade secrets in healthcare
Did you know that one-third of healthcare companies have suffered from trade secrets theft? What are firms doing to protect their trade secrets? This webinar provides insights on how to reduce the risk of trade secrets theft.
The Fake Drug Industry: A strategic view of global enforcement
The session focuses on anti-counterfeiting in the pharmaceutical industry, covering comparative enforcement regimes and recent legal developments.
A Buyer's Guide to M&A in Latin America: A focus on healthcare
The webinar provides insights on the healthcare M&A outlook in the region, getting deals done in the current economic context and regulatory, compliance and due diligence tips.
Preparing for international tax reform (BEPS 2.0) from the perspective of healthcare companies (hosted by Lexology)
Contact Cristina Barrobes and Jettie Groot for a copy of the recording.
Focuses on the potential tax implications for pharmaceutical and medical technology companies of the OECD's blueprints for Pillar One and Pillar Two of the BEPS project. The second half of the webinar features a panel with tax directors from the industry on their thoughts on how they see BEPS 2.0 changing the role of tax in shaping the business models of the future and how tax departments can prepare for what is looming on the not-so-distant horizon.